Stephen Ferruolo - Neurobiological Technologies Sec
| NTIIDelisted Stock | USD 0.0001 0.00 0.00% |
Insider
Stephen Ferruolo is Sec of Neurobiological Technologies
| Phone | 510 595 6000 |
| Web | http://www.ntii.com |
Similar Executives
| Found 7 records | INSIDER Age | ||
| Ruud Outersterp | Pharming Group NV | 59 | |
| MBA MD | Pharming Group NV | 63 | |
| Stephen Toor | Pharming Group NV | 52 | |
| Anurag Relan | Pharming Group NV | 51 | |
| Susanne Embleton | Pharming Group NV | N/A | |
| Mireille MSc | Pharming Group NV | 55 | |
| Jeroen Wakkerman | Pharming Group NV | 54 | |
Management Performance
Neurobiological Technologies Leadership Team
Elected by the shareholders, the Neurobiological Technologies' board of directors comprises two types of representatives: Neurobiological Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Neurobiological. The board's role is to monitor Neurobiological Technologies' management team and ensure that shareholders' interests are well served. Neurobiological Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Neurobiological Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Stuppin, Founder, Director, Chairman of Nominating and Corporate Governance Committee and Member of Special Committee | ||
| Stephen Ferruolo, Sec |
Neurobiological Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Neurobiological Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.0 | ||||
| Profit Margin | 0.74 % | ||||
| Operating Margin | 0.77 % | ||||
| Current Valuation | (26.24 M) | ||||
| Shares Outstanding | 27.02 M | ||||
| Shares Owned By Institutions | 9.41 % | ||||
| Number Of Shares Shorted | 37.6 K | ||||
| Price To Book | 0.07 X | ||||
| Price To Sales | 0.0004 X | ||||
| Revenue | 6.03 M |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Neurobiological Stock
If you are still planning to invest in Neurobiological Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobiological Technologies' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |